Helio Health
Alex Brenner is a finance professional with extensive experience in various sectors, currently serving as the Chief Financial Officer at Helio Genomics since March 2020, where responsibilities include leading fundraising efforts, building finance teams, and overseeing strategic corporate initiatives. Prior to Helio Genomics, Alex held the position of Director of Accounting and Finance at Code.org, managing financials for a technology non-profit. Alex's earlier career at Republic Services included roles from Area Director of Business Development to Finance Manager, contributing to significant revenue growth and contract negotiations. Alex started the career as a Senior Accountant at Infinity Internet and holds an MBA in Finance from Oregon State University and a BA in Economics and Political Science from UC San Diego.
This person is not in any offices
Helio Health
Helio Health is an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw. The company’s mission is to simplify cancer screening so lives can be saved by detecting cancer earlier. With Helio’s AI-driven technology, both physicians and their patients gain powerful insights from accurate,accessible, and convenient blood tests. Helio’s development program is focused on liver, colon, breast and lung cancer. Helio Health is headquartered in Irvine, CA, with R&D, GMP and CLIA facilities in Irvine, CA and West Lafayette, IN.